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A novel duplex PCR method based on variable-number tandem-repeat targets to discriminate among
Mycobacterium abscessus complex isolates was developed and evaluated in 85 clinical isolates. The assay
accuracy was confirmed by a multiple-target sequence analysis. The duplex PCR assay is a one-step, reliable,
and accurate assay for discriminating M. abscessus species.
Mycobacterium abscessus belongs to a group of rapidly grow-
ing mycobacteria (RGM) that cause a wide spectrum of infec-
tions in humans (6, 17). Recently, M. abscessus complex was
divided into three closely related Mycobacterium species: M.
abscessus (sensu stricto) (hereafter referred to as M. absces-
sus), M. massiliense, and M. bolletii (1, 4).
M. abscessus is the most drug-resistant mycobacterial species
known and exhibits unsatisfactory treatment response rates,
especially for patients with pulmonary disease (6, 17). Induc-
ible resistance of M. abscessus to clarithromycin has been sug-
gested as an explanation for the lack of efficacy of clarithro-
mycin-based treatments against the bacterium (14). In
contrast, M. massiliense shows marked susceptibility to clari-
thromycin due to the absence of inducible resistance to mac-
rolides (8). Therefore, treatment response rates to clarithro-
mycin-based antibiotic therapy are higher in patients with M.
massiliense than in those with M. abscessus lung disease (10).
M. bolletii, a rare pathogen at present, has also been shown to
be highly resistant to clarithromycin (3, 9, 11).
Since recent studies suggest that antibiotic susceptibility and
treatment outcomes differ significantly among these species,
the species-level identification of M. abscessus complex isolates
has been strongly recommended in order to determine the
clinical significance and to assist in managing patients (8, 10).
Despite progress in our ability to identify mycobacterial spe-
cies using molecular methods, M. abscessus complex isolates
cannot be reliably identified at the species level by sequencing
a single genetic locus such as rpoB or hsp65 (13). Currently, the
species-level identification of M. abscessus complex solely de-
pends on multiple sequencing analysis targeting several genes,
including rpoB, hsp65, gnd, glpK, secA, and sodA (2, 13, 15).
This process requires a number of additional, laborious steps
(e.g., cloning) to obtain the sequences of the products, leading
to expensive and complicated procedures that must be done in
reference laboratories.
Increasingly, variable-number tandem-repeat (VNTR) ana-
lyses have been used for the molecular typing of isolated my-
cobacterial strains as well as for mycobacterial species identi-
fication (7, 16). In this study, a novel duplex PCR method
based on variable-number tandem-repeat targets to discrimi-
nate among Mycobacterium abscessus complex isolates was de-
veloped and evaluated in 85 clinical isolates.
A total of 85 clinical isolates were collected between January
2001 and December 2006 in the Samsung Medical Center,
Seoul, South Korea, according to the diagnostic criteria pub-
lished by the American Thoracic Society (17). The 85 strains
were initially identified as M. abscessus by PCR-restriction
fragment length polymorphism (PRA) analysis of rpoB (12).
To obtain our VNTR targets, the entire genome of M. ab-
scessus ATCC 19977 (GenBank accession no. CU458896.1)
was examined using a tandem repeat finder program (http:
//tandem.bu.edu/trf/trf.html). In target loci from the 1,496 re-
peats initially selected by the program, the 16 loci were se-
lected according to the following criteria; repeat number of at
least twice, sequence match of at least 85%, and a longer
period size than 20 bp. Screening of the 16 selected loci was
done against three reference strains, M. abscessus ATCC
19977, M. massiliense CIP108297, and M. bolletii CIP108541.
During screening, two loci were identified that could discrim-
inate among the members of the M. abscessus complex. The
two pairs of primers, VNTR11 and Mab2, amplified the fol-
lowing regions of the M. abscessus ATCC 19977 genome:
2951442 to 2952583 (designated VNTR11) and 4058506 to
4058576 (designated VNTR23) (Table 1). The DNA template
was amplified in a 20-l volume using the two pairs of primers
(1 M each primer). The amplification profile consisted of 10
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min at 95°C, followed by 30 cycles, with 1 cycle consisting of
30 s at 95°C, 30 s at 63°C, and 45 s at 72°C. We extended the
established method to 85 clinical strains independently identi-
fied by a multiple-target sequence analysis of rpoB, hsp65, gnd,
and glpK as previously described (Table 1) (2, 5, 12).
Complete identity agreement was found between the two
assays, and both methods revealed that the 85 clinical strains
were subdivided into 42 M. abscessus strains, 39 M. massiliense
strains, and 4 M. bolletii strains. In further characterization of
the 85 strains, VNTR11 showed a length polymorphism of two
to four copies (179 to 278 bp) in M. abscessus with only one
copy in M. massiliense and M. bolletii. VNTR23 was present as
one to three copies (196 to 238 bp) in M. abscessus, while M.
bolletii showed one pattern with two copies of VNTR23. Inter-
estingly, none of the M. massiliense strains were positive for
VNTR23 (Fig. 1).
For the easy and precise differentiation of M. abscessus spe-
cies, duplex PCR with redesigned primers, Mab1 and Mab2,
was developed to avoid amplification overlaps between the two
loci (Fig. 2). Capillary electrophoresis (Agilent Technologies,
Waldbronn, Germany) was applied to ensure accurate differ-
entiation of amplicon size. The primer specificity of the two
VNTR targets was evaluated by performing PCR under the
same conditions using six clinically important mycobacteria
(M. terrae ATCC 15755, M. chelonae ATCC 35752, M. avium
complex ATCC 25291, M. peregrinum ATCC 14467, M. fortui-
TABLE 1. Characterization of the two VNTR loci and primers used in this study
VNTR locus or multiple-
target gene
ORF involveda
(repeat  copy no.)
Amplification
size (bp) Primer
b Primer sequence
Two VNTR loci
VNTR11 MAB 2899c (33  4  11c) 179 to 278 VNTR11-F 5-GAACACCTCAACCGCAGTG
VNTR11-R 5-CATTAGCGCGATAGGCTCAC
393 to 492 Mab1-Fd 5-CCTCGAGCCCAAGATCTGTC
Mab1-Rd 5-ATACCGGGATACGCCAAGAT
VNTR23 Intergenice (21  3  7) 196 to 238 Mab2-Ff 5-AAGGGACTGGGACTGATCG
Mab2-Rf 5-CCGGAGACCGACCTCTTC
Multiple-target genesg
rpoB 360 rpo-F 5-TCAAGGAGAAGCGCTACGA
rpo-R 5-GGATGTTGATCAGGGTCTGC
hsp65 441 hsp-F 5-ACCAACGATGGTGTGTCCAT
hsp-R 5-CTTGTCGAACCGCATACCCT
gnd 634 gnd-F 5-GTGACGTCGGAGTGGTTGG
gnd-R 5-CTTCGCCTCAGGTCAGCTC
glpK 609 glp-F 5-AATCTCACCGGCGGTGTC
glp-R 5-GGACAGACCCACGATGGC
a Putative open reading frames (ORFs) were presented in the whole genome of M. abscessus ATCC 19977.
b The orientation of the primer is indicated by a letter at the end of the primer name as follows: F, forward; R, reverse.
c Repeat size (bp), complete copy number, and partial repeat sequence (bp) in M. abscessus ATCC 19977.
d The redesigned primers of VNTR11 for the duplex PCR.
e The intergenic sequence is located between MAB4014 and 4015c in M. abscessus ATCC 19977.
f Identical to VNTR23.
g Sequence analysis of these genes followed by cloning was used as a confirmatory method for the identification of M. abscessus species.
FIG. 1. Amplified products obtained by PCR using the VNTR11 and VNTR23 primer sets. (A) VNTR11 consists of one to four copy numbers
(179 to 278 bp) with a 33-bp tandem repeat. (B) VNTR23 consists of one to three copy numbers (196 to 238 bp) with a 21-bp tandem repeat. In
85 clinical isolates, M. abscessus showed two to four copies of VNTR11 and one or two copies of VNTR23. In comparison, M. bolletii showed one
copy of VNTR11 and two copies of VNTR23; M. massiliense showed one copy of VNTR11. M. massiliense showed no tandem repeats (non). Lanes
M, molecular size markers (in base pairs); lanes 1, 2, 3, and 4, M. abscessus SM56, 25, 14, and 50, respectively; lanes 5 and 6, M. massiliense SM04
and 38, respectively; lanes 7 and 8, M. bolletii SM19 and 61, respectively.
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tum ATCC 6841, and M. tuberculosis H37Rv). No amplification
was seen in any of the mycobacterial species tested (data not
shown).
The duplex PCR of M. abscessus complex provides a simple
criterion for interpretation: if there is one band on the gel (one
amplification product with primer Mab1 only), the result is
positive for M. massiliense; when two amplification bands
(Mab1 and Mab2 primers) are displayed, they are either M.
abscessus (393 bp) or M. bolletii (393 bp); and if there is a
band of 393 bp in length, the result is interpreted as M.
abscessus.
This is the first study to demonstrate the precise identifica-
tion of M. abscessus complex to the species level using VNTR
targets. The assay not only accurately distinguished M. absces-
sus complex isolates from other mycobacterial species, includ-
ing M. chelonae and M. fortuitum, but also discriminated
among M. abscessus complex isolates to the species level.
An effective discrimination among closely related yet patho-
genetically diverse members of M. abscessus complex will
support a better diagnosis and treatment regimen as well as
further our understanding of the epidemiology of these patho-
gens.
To extend these results, studies of the association between
clinical outcomes, distinct pathogenesis, drug resistance, and
VNTR profile using a greater number of VNTR targets are
under way.
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FIG. 2. Representative images showing duplex PCR results obtained by agarose gel (A) and capillary electrophoresis (B). Lane M, molecular
size markers (in base pairs); lanes 1 to 5, M. abscessus SM56, 25, 14, 32, and 50, respectively; lane 6, M. massiliense SM04; lane 7, M. bolletii SM19.
The amplified products of Mab1 and Mab2 correspond to the top and bottom bands, respectively.
VOL. 49, 2011 NOTES 1109
